SCHEMBL13154178

SCHEMBL13154178

N=C(Cl)C(=N)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624173 0.77
SCHEMBL10530939 0.77
SCHEMBL20958228 0.72
SCHEMBL15246734 0.72
Ammonia Solution, Strong SCHEMBL5017396 0.71
Hydrochloric Acid SCHEMBL388311 0.71
SCHEMBL62149 0.67
SCHEMBL20552705 0.67
SCHEMBL12332913 0.67
SCHEMBL2131555 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016029077-A1 NOVEL N2, N4, N7, 6-TETRASUBSTITUTED PTERIDINE-2,4,7-TRIAMINE AND 2, 4, 6, 7-TETRASUBSTITUTED PTERIDINE COMPOUNDS AND METHODS OF SYNTHESIS AND USE THEREOF JANUS BIOTHERAPEUTICS, INC. (US) 2016-02-25 WO disclosed
WO-2010123792-A1 PREPARATION OF C-PYRAZINE-METHYLAMINES OSI PHARMACEUTICALS, INC. (US) 2010-10-28 WO disclosed
WO-2007071639-A1 SUBSTITUTED PYRAZINONE DERIVATIVES AS ALPHA2C-ADRENORECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-06-28 WO disclosed